2-Bromo-5-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 1g

Ethyl 1-aminocyclopentanecarboxylate hydrochloride, 95.0%, 5g

Cubreobjetos grosor 1 vuelta, 20 mm 1000 uds.

N-butyl-N-methylpyrrolidinium bis((trifluoromethyl)sulfonyl)imide, 98.0%, 25g

4-Phenylquinazolin-2(1H)-one, 95.0%, 5g

Capecitibine, 99.0%, 5g

BIS(4-(OXIRAN-2-YLMETHYL)PHENYL)METHANE, 95.0%, 250mg

4-BROMO-1-(4-METHOXYBENZYL)-1H-PYRAZOL-5-AMINE, 95.0%, 1g

(5-(Methoxycarbonyl)-1-tosyl-1H-pyrrol-3-yl)boronic acid, 95.0%, 250mg

(2R)-4,4-Difluoropyrrolidine-2-carboxylic acid, 97%, 250mg

2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol, 95.0%, 100g

4-Bromo-3-cyanobenzoic acid, 95.0%, 5g

Droxidopa>98.0%(HPLC)(T)50mg